Cargando…

Activated macrophages promote Wnt signalling through tumour necrosis factor-α in gastric tumour cells

The activation of Wnt/β-catenin signalling has an important function in gastrointestinal tumorigenesis. It has been suggested that the promotion of Wnt/β-catenin activity beyond the threshold is important for carcinogenesis. We herein investigated the role of macrophages in the promotion of Wnt/β-ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oguma, Keisuke, Oshima, Hiroko, Aoki, Masahiro, Uchio, Ryusei, Naka, Kazuhito, Nakamura, Satoshi, Hirao, Atsushi, Saya, Hideyuki, Taketo, Makoto Mark, Oshima, Masanobu
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2008
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2413189/ https://www.ncbi.nlm.nih.gov/pubmed/18511911 http://dx.doi.org/10.1038/emboj.2008.105

Ejemplares similares

Context-dependent activation of Wnt signaling by tumor suppressor RUNX3 in gastric cancer cells
por: Ju, Xiaoli, et al.
Publicado: (2014)

FOXO3 is a latent tumor suppressor for FOXO3-positive and cytoplasmic-type gastric cancer cells
por: Tsuji, Toshikatsu, et al.
Publicado: (2021)

Intratumoral induction of tumour necrosis factor by systemic administration of Bordetella pertussis vaccine.
por: Minagawa, H., et al.
Publicado: (1990)

Stat3 is indispensable for damage-induced crypt regeneration but not for Wnt-driven intestinal tumorigenesis
por: Oshima, Hiroko, et al.
Publicado: (2019)

Development of spontaneous tumours and intestinal lesions in Fhit gene knockout mice
por: Fujishita, T, et al.
Publicado: (2004)

ROCK-I regulates closure of the eyelids and ventral body wall by inducing assembly of actomyosin bundles
por: Shimizu, Yoshihiko, et al.
Publicado: (2005)

ETC-159, an Upstream Wnt inhibitor, Induces Tumour Necrosis via Modulation of Angiogenesis in Osteosarcoma
por: Chua, Kenon, et al.
Publicado: (2023)

NF-κB-induced NOX1 activation promotes gastric tumorigenesis through the expansion of SOX2-positive epithelial cells
por: Echizen, Kanae, et al.
Publicado: (2019)

Regulation of tumour related genes by dynamic epigenetic alteration at enhancer regions in gastric epithelial cells infected by Epstein-Barr virus
por: Okabe, Atsushi, et al.
Publicado: (2017)

Mouse gastric tumor models with prostaglandin E(2 )pathway activation show similar gene expression profiles to intestinal-type human gastric cancer
por: Itadani, Hiraku, et al.
Publicado: (2009)

The Relationship of Fever to Tumour Necrosis in the Rat
por: Allen, Ingrid V.
Publicado: (1964)

Novel oral transforming growth factor‐β signaling inhibitor EW‐7197 eradicates CML‐initiating cells
por: Naka, Kazuhito, et al.
Publicado: (2016)

Effects on tumour microcirculation in mice of misonidazole and tumour necrosis factor plus hyperthermia.
por: Fujimoto, S., et al.
Publicado: (1992)

Characterization of RNF43 frameshift mutations that drive Wnt ligand‐ and R‐spondin‐dependent colon cancer
por: Yamamoto, Daisuke, et al.
Publicado: (2022)

Enhanced anti-tumour activity of carmustine (BCNU) with tumour necrosis factor in vitro and in vivo.
por: Jones, A. L., et al.
Publicado: (1990)

Tumour-infiltrating lymphocytes bear the 75 kDa tumour necrosis factor receptor.
por: Trentin, L., et al.
Publicado: (1995)

Carnitine and congeners as regulators of tumour necrosis factor
por: De Simone, Claudio, et al.
Publicado: (1993)

Tumour necrosis factor-α in nasal allergy
por: Hisamatsu, K., et al.
Publicado: (1995)

Postchemoembolisation syndrome – tumour necrosis or hepatocyte injury?
por: Wigmore, S J, et al.
Publicado: (2003)

Tumour necrosis factor signalling in health and disease
por: Holbrook, Jonathan, et al.
Publicado: (2019)

Tumour necrosis factor production and natural killer cell activity in peripheral blood during treatment with recombinant tumour necrosis factor.
por: MÃ¤nnel, D. N., et al.
Publicado: (1989)

Molecular design of hybrid tumour necrosis factor-alpha. II: The molecular size of polyethylene glycol-modified tumour necrosis factor-alpha affects its anti-tumour potency.
por: Tsutsumi, Y., et al.
Publicado: (1996)

Genetic Alterations and Microenvironment that Drive Malignant Progression of Colorectal Cancer: Lessons from Mouse and Organoid Models
por: Nakayama, Mizuho, et al.
Publicado: (2022)

Genetic and nongenetic mechanisms for colorectal cancer evolution
por: Kok, Sau Yee, et al.
Publicado: (2023)

Anti-tumour activity of low-toxicity lipopolysaccharide of Bordetella pertussis.
por: Ohnishi, M., et al.
Publicado: (1994)

Relationship between tumour cell morphology, gap junctions and susceptibility to cytolysis by tumour necrosis factor.
por: Matthews, N., et al.
Publicado: (1989)

Polymorphisms in tumour necrosis factor (TNF) are associated with risk of bladder cancer and grade of tumour at presentation
por: Marsh, H P, et al.
Publicado: (2003)

Higher serum levels of tumour necrosis factor and its soluble receptors are associated with ovarian tumours
por: Mielczarek-Palacz, Aleksandra, et al.
Publicado: (2012)

The antimicrobial peptide defensin cooperates with tumour necrosis factor to drive tumour cell death in Drosophila
por: Parvy, Jean-Philippe, et al.
Publicado: (2019)

A first report of tumour-tracking radiotherapy with helical tomotherapy for lung and liver tumours: A double case report
por: Okada, Wataru, et al.
Publicado: (2021)

Polymorphism in the tumour necrosis factor receptor II gene is associated with circulating levels of soluble tumour necrosis factor receptors in rheumatoid arthritis
por: Glossop, John R, et al.
Publicado: (2005)

A Study of Single Nucleotide Polymorphisms of Tumour Necrosis Factor α-1031 And Tumour Necrosis Factor β+ 252 in Chronic Rhinosinusitis
por: Misron, Khairunnisak, et al.
Publicado: (2017)

Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressiveness
por: Avgustinova, Alexandra, et al.
Publicado: (2016)

Functional loss of p53 cooperates with the in vivo microenvironment to promote malignant progression of gastric cancers
por: Ohtsuka, Junko, et al.
Publicado: (2018)

Tumour necrosis factor in man: clinical and biological observations.
por: Selby, P., et al.
Publicado: (1987)

Tumour necrosis factor-dependent inflammatory cartilage destruction
por: Korb, A, et al.
Publicado: (2007)

Necrosis and apoptosis in Trichinella spiralis-mediated tumour reduction
por: Vasilev, Sasa, et al.
Publicado: (2015)

Immunological and prognostic significance of tumour necrosis in colorectal cancer
por: Kastinen, Meeri, et al.
Publicado: (2023)

The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor
por: Harrold, Leslie R, et al.
Publicado: (2015)

Effect of human recombinant tumour necrosis factor and rat gamma interferon on nitrosomethylurea-induced mammary tumours.
por: Shah, P., et al.
Publicado: (1989)

Cannot write session to /tmp/vufind_sessions/sess_9reac34f2imchn0nab3ominhc6